surmount-1 tirzepatide weight loss nondiabetic reduction over time in tirzepatide‐treated participants by early weight response: Post hoc analysis in SURMOUNT‐1 - Ard - 2025 - Diabetes, Obesity and Metabolism tirzepatide obesity trial non-diabetic as

Way forward All expert perspectives point toward a future where the success of GLP-1 therapies depends on how strong our engineering and logistics are

Image Credit: zimmytws / Shutterstock A recent review published in The Nurse Practitioner highlights the expanding clinical role of glucagon-like peptide-1 receptor agonists (GLP-1RAs), which have also drawn widespread media attention for their rapid weight-loss effects

What happens if you eat sugar on Wegovy

On average, tirzepatide weight loss results in just over a year (72 weeks) are: 15% weight loss on 5 mg 19.5% weight loss on 10 mg 20.9% weight loss on 15 mg So, for a 200-pound person, this works out to: 30 pounds on 5 mg 40 pounds on 10 mg 42 pounds on 15 mg In comparison, people who did not take tirzepatide lost only 3.1% of their body weight (about 6 pounds for a 200-pound person)